244 related articles for article (PubMed ID: 33724957)
1. Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury.
Guillot A; Guerri L; Feng D; Kim SJ; Ahmed YA; Paloczi J; He Y; Schuebel K; Dai S; Liu F; Pacher P; Kisseleva T; Qin X; Goldman D; Tacke F; Gao B
J Clin Invest; 2021 May; 131(9):. PubMed ID: 33724957
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis.
Hisamoto S; Shimoda S; Harada K; Iwasaka S; Onohara S; Chong Y; Nakamura M; Bekki Y; Yoshizumi T; Ikegami T; Maehara Y; He XS; Gershwin ME; Akashi K
J Autoimmun; 2016 Dec; 75():150-160. PubMed ID: 27592379
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
4. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
[TBL] [Abstract][Full Text] [Related]
5. Role of integrin αvβ6 in the pathogenesis of ischemia-related biliary fibrosis after liver transplantation.
Chen G; Zhang L; Chen L; Wang H; Zhang Y; Bie P
Transplantation; 2013 May; 95(9):1092-9. PubMed ID: 23422496
[TBL] [Abstract][Full Text] [Related]
6. Sortilin in Biliary Epithelial Cells Promotes Ductular Reaction and Fibrosis during Cholestatic Injury.
Hubel E; Neumann A; Fishman S; Schaffer O; Erez N; Shrkihe BA; Shteingard Y; Gross T; Shibolet O; Varol C; Zvibel I
Am J Pathol; 2024 Jun; 194(6):941-957. PubMed ID: 38493927
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles.
Verhulst S; Roskams T; Sancho-Bru P; van Grunsven LA
Cells; 2019 Sep; 8(10):. PubMed ID: 31547151
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor Klf5 is essential for intrahepatic biliary epithelial tissue remodeling after cholestatic liver injury.
Okada H; Yamada M; Kamimoto K; Kok CY; Kaneko K; Ema M; Miyajima A; Itoh T
J Biol Chem; 2018 Apr; 293(17):6214-6229. PubMed ID: 29523685
[TBL] [Abstract][Full Text] [Related]
10. Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.
Tatler AL; Goodwin AT; Gbolahan O; Saini G; Porte J; John AE; Clifford RL; Violette SM; Weinreb PH; Parfrey H; Wolters PJ; Gauldie J; Kolb M; Jenkins G
PLoS One; 2016; 11(8):e0158047. PubMed ID: 27494713
[TBL] [Abstract][Full Text] [Related]
11. Regulation and function of trefoil factor family 3 expression in the biliary tree.
Nozaki I; Lunz JG; Specht S; Park JI; Giraud AS; Murase N; Demetris AJ
Am J Pathol; 2004 Dec; 165(6):1907-20. PubMed ID: 15579435
[TBL] [Abstract][Full Text] [Related]
12. Sox9
Tulasi DY; Castaneda DM; Wager K; Hogan CB; Alcedo KP; Raab JR; Gracz AD
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1437-1462. PubMed ID: 33497866
[TBL] [Abstract][Full Text] [Related]
13. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction.
Liu Z; Sakamoto T; Yokomuro S; Ezure T; Subbotin V; Murase N; Contrucci S; Demetris AJ
Liver; 2000 Apr; 20(2):114-24. PubMed ID: 10847479
[TBL] [Abstract][Full Text] [Related]
14. Role of alphavbeta6 integrin in acute biliary fibrosis.
Wang B; Dolinski BM; Kikuchi N; Leone DR; Peters MG; Weinreb PH; Violette SM; Bissell DM
Hepatology; 2007 Nov; 46(5):1404-12. PubMed ID: 17924447
[TBL] [Abstract][Full Text] [Related]
15. Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction.
Kossor DC; Goldstein RS; Ngo W; DeNicola DB; Leonard TB; Dulik DM; Meunier PC
Fundam Appl Toxicol; 1995 Jun; 26(1):51-62. PubMed ID: 7657062
[TBL] [Abstract][Full Text] [Related]
16. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
Kitamura T; Srivastava J; DiGiovanni J; Kiguchi K
Mol Carcinog; 2015 Jun; 54(6):459-72. PubMed ID: 24839254
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice.
Pi L; Robinson PM; Jorgensen M; Oh SH; Brown AR; Weinreb PH; Trinh TL; Yianni P; Liu C; Leask A; Violette SM; Scott EW; Schultz GS; Petersen BE
Hepatology; 2015 Feb; 61(2):678-91. PubMed ID: 25203810
[TBL] [Abstract][Full Text] [Related]
18. Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells.
Sullivan BP; Kassel KM; Manley S; Baker AK; Luyendyk JP
J Pharmacol Exp Ther; 2011 May; 337(2):471-8. PubMed ID: 21303922
[TBL] [Abstract][Full Text] [Related]
19. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
Lunz JG; Contrucci S; Ruppert K; Murase N; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 2001 Apr; 158(4):1379-90. PubMed ID: 11290556
[TBL] [Abstract][Full Text] [Related]
20. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
